SINGAPORE, Dec. 03, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jason Leow as a Senior Managing Director within the firm’s Strategic Communications segment. Mr. Leow, who is based in Singapore, brings more than 25 years of experience in financial communications, C-suite advisory and stakeholder engagement across Asia, Europe and the United States. In his role at FTI Consulting, he will work closely with the Asia Leadership Team and the firm’s global Senior Ma ...

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mustang Energy Corp. (CSE: MEC, OTC: MECPF, FRA: 92T) (the “Company” or “Mustang”) is pleased to announce that it has staked two new mineral exploration properties in Newfoundland and Labrador — the Onyx Uranium Project (the “Onyx Project”) in southern Newfoundland and the Bridal Veil Copper–Silver Project (the “Bridal Veil Project”) in central Newfoundland — consisting of a combined 446 claims totaling approximately 3,875 hectares. Together, th ...

Proceeds will be used to continue growing and upgrading the Mineral Resource and advance Upscaled Economic Studies in lead up to a Final Investment DecisionNot for distribution to U.S. news wire services or dissemination in the United States. Green Bay Copper-Gold Project, Canada FireFly has received firm commitments totalling approximately A$134.1m (before costs) via a Charity Flow-Through Placement, Institutional Placement, and Canadian bought deal financingFireFly also intends to undertake a non-underwri ...

NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN U.S. OR FOR DISSEMINATION IN U.S. MISSISSAUGA, Ontario, Dec. 03, 2025 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that Kruger Products Inc. (“KPI”) has, pursuant to an underwriting agreement entered into today, agreed to issue and sell CDN $165 million principal amount of 6.250% Senior Unsecured Notes (the “Notes”) due December 10, 2032 by way of private placement (the “Offering”). Interest on the Notes is payable semi-annually in arrears ...

Core Insights - Mesoblast Limited is a global leader in allogeneic cellular medicines for inflammatory diseases and is participating in the Piper Sandler 37th Annual Healthcare Conference in New York from December 2–4, 2025 [1][2] Company Overview - Mesoblast specializes in developing allogeneic (off-the-shelf) cellular medicines aimed at treating severe and life-threatening inflammatory conditions, utilizing a proprietary mesenchymal lineage cell therapy technology platform [3] - The company has a strong intellectual property portfolio with over 1,000 granted patents or patent applications, providing commercial protection extending through at least 2044 in major markets [6] Product Development - Mesoblast's Ryoncil (remestemcel-L-rknd) is the first FDA-approved mesenchymal stromal cell therapy for treating steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients aged 2 months and older [4] - The company is developing additional therapies for various inflammatory diseases, including SR-aGvHD in adults and biologic-resistant inflammatory bowel disease, as well as rexlemestrocel-L for heart failure and chronic low back pain [5] Manufacturing Capabilities - Mesoblast employs proprietary manufacturing processes that yield industrial-scale, cryopreserved, off-the-shelf cellular medicines, ensuring these therapies are readily available to patients worldwide [7] Global Presence - The company operates in Australia, the United States, and Singapore, and is listed on both the Australian Securities Exchange (MSB) and Nasdaq (MESO) [8]

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started treatment at an early stage New safety and efficacy data presented at scientific symposium on subcutaneous formulation for LEQEMBI initiation treatment, which is under regulatory review in the United States TOKYO and CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Ha ...

Group 1 - LGI Homes, Inc. closed 398 homes in November 2025, including 8 single-family rental homes [1] - As of November 30, 2025, the company had 140 active selling communities [1] Group 2 - LGI Homes is headquartered in The Woodlands, Texas, and operates in 36 markets across 21 states [2] - The company has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year [2] - LGI Homes has been recognized for its quality construction and exceptional customer service, being named to Newsweek's list of the World's Most Trustworthy Companies [2] - The company employs over 1,000 individuals and has received numerous workplace awards, including the Top Workplaces USA 2025 Award [2]

TORONTO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Future Mineral Resources Inc. (formerly Sulliden Mining Capital Inc.) (“Future Mineral” or the “Company”) (TSX: FMR) is pleased to announce that Dr. Andreas Rompel has been appointed as a director of the Company, effective immediately. Dr. Rompel is a seasoned exploration professional with more than three decades of exploration and mining experience in a wide range of roles from VP Exploration and Project Manager to Country Manager and Corporate Development. Dr. Ro ...

NORTH WALES, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Toppoint Holdings Inc. (the “Company”) announced today that A.G.P./Alliance Global Partners, the representative of the underwriters in the Company’s recent public sale of shares of its common stock, are waiving a lock-up restriction with respect to 7,500,000 shares of its common stock held by an officer of the Company. The waiver will take effect immediately, and the shares of its common stock may be sold on or after such date. This press release is not an ...

Core Insights - Xtract One Technologies Inc. reported a record backlog of over $53 million, indicating strong revenue growth potential for fiscal 2026 and beyond [3] - The company successfully ramped up the commercial deployment of its Xtract One Gateway, with new bookings totaling $5.1 million from seven customers in the first quarter [3] - A public offering raised gross proceeds of over $11.5 million, enhancing the company's capacity to meet customer demand and invest in business development [3] Financial Performance - Consolidated revenue for the first quarter ended October 31, 2025, was $4.6 million, up from $3.6 million in the same period last year, driven by the initial commercial deployments of Xtract One Gateway [4][6] - Gross profit was $2.7 million, with a gross profit margin of 58%, compared to $2.3 million and a margin of 64% in the prior-year period, due to higher initial production and installation costs [4][6] - Comprehensive loss for the quarter was $3.0 million, slightly higher than the $2.7 million loss in the same period last year, primarily due to unrealized foreign currency translation adjustments [5][6] Operational Highlights - The total contract value of new bookings reached $8.4 million for the quarter, compared to $4.2 million in the prior-year period [6] - Contractual backlog at the end of the first quarter was $14.1 million, a slight increase from $14.0 million in the previous year, excluding an additional $39.1 million in agreements pending installation [6] - The company is working with its manufacturing partner to increase production capacity to meet current and forecasted demand for Xtract One Gateway by the end of the second quarter of fiscal 2026 [3] Cash Flow and Financial Position - Cash and cash equivalents increased to $9.1 million as of October 31, 2025, from $8.2 million at the end of the previous quarter [17][18] - The company reported cash used in operating activities of $1.2 million for the quarter, an improvement compared to $1.95 million in the same period last year [18] - Total assets as of October 31, 2025, were $23.7 million, up from $23.4 million at the end of July 2025 [17]